Your browser doesn't support javascript.
loading
Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC.
Lee, Se-Hoon; Lee, June-Koo.
Affiliation
  • Lee SH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea. Electronic address: shlee119@skku.edu.
  • Lee JK; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
Lancet Respir Med ; 5(2): e10, 2017 02.
Article in En | MEDLINE | ID: mdl-28145234
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Carcinoma, Non-Small-Cell Lung Limits: Humans Language: En Journal: Lancet Respir Med Year: 2017 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Carcinoma, Non-Small-Cell Lung Limits: Humans Language: En Journal: Lancet Respir Med Year: 2017 Document type: Article